FCPM III Services’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Hold
3,468,430
2.23% 9
2025
Q4
$24.6M Buy
3,468,430
+16,100
+0.5% +$119K 3.22% 8
2025
Q3
$26.7M Hold
3,452,330
5.34% 5
2025
Q2
$24M Hold
3,452,330
6.5% 5
2025
Q1
$29.3M Hold
3,452,330
7.08% 5
2024
Q4
$48.3M Buy
3,452,330
+1,112,369
+48% +$23.8M 8.16% 4
2024
Q3
$53M Buy
2,339,961
+217,069
+10% +$5.01M 9.09% 5
2024
Q2
$43M Buy
+2,122,892
New +$48M 6.34% 5

Other funds holding BCYC

FCPM III Services's BCYC Position: Q1 2026 in Review

FCPM III Services held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 3,468,430 shares worth $16.1M. The position accounts for 2.23% of the portfolio, ranked #9.

FCPM III Services first reported a position in BCYC in Q2 2024 and has held it in 8 quarters since. The position peaked at $53M in Q3 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • FCPM III Services held 3,468,430 shares of Bicycle Therapeutics worth $16.1M as of Q1 2026.
  • FCPM III Services left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up 2.23% of FCPM III Services's portfolio in Q1 2026, its #9 holding.
  • FCPM III Services first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • FCPM III Services's Bicycle Therapeutics position peaked at $53M in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on FCPM III Services's 13F filing for Q1 2026, filed 15 May 2026.